Women With Chest Pain and Normal Coronary Arteries Study
NCT00743197 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2023-12-12
Summary
The purpose of this study is to compare the effectiveness of standard medical therapy versus usual care in women with chest pain, coronary endothelial dysfunction and unblocked coronary arteries.
Coronary endothelial dysfunction (CED) is a condition in which the layers of cells around the heart do not function properly and is believed to be key factor in the development of atherosclerosis (fat deposits in arteries). In addition, CED is associated with an increased risk for future cardiovascular events, such as heart attack and stroke.
A coronary angiogram allows physicians to see if any of the arteries in the heart are blocked, usually by fatty plaque. In many instances, angiograms in women experiencing chest pain do not show evidence of coronary disease (free of significant plaque build-up). Currently, there is no standard of care treatment plan for patients with normal coronary arteries, despite symptoms of chest pain, and as a result these patients may not receive medical treatment. However, these women often return to their physicians more than once with chest pain and go through a similar battery of tests.
Conditions
Interventions
- DRUG
-
Aspirin 81 mg daily
- DRUG
-
Lisinopril
Lisinopril 10 mg every night
- DRUG
-
Simvastatin
Simvastatin 20 mg every night
- DRUG
-
Lovaza
Lovaza 1 gram daily
- BEHAVIORAL
-
Therapeutic Lifestyle Changes
Therapeutic lifestyle changes will be initiated with the assistance of a dietician, including diet counseling, exercise recommendation, and weight maintenance/weight loss.
Sponsors & Collaborators
-
Astellas Pharma US, Inc.
collaborator INDUSTRY - lead OTHER
Principal Investigators
-
Martha Gulati, MD · Northwestern University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 90 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2010-05-31
- Completion
- 2010-05-31
Countries
- United States
Study Locations
More Related Trials
-
Aspirin Dose and Atherosclerosis in Patients With Heart Disease
NCT00272337 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy
NCT01852162 ·Status: COMPLETED ·Phase: NA
-
Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
NCT00222261 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
NCT01586975 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Platelet-Inhibitor Drug Trial in Coronary Angioplasty
NCT00000510 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin Resistance in Coronary Artery Disease
NCT00753935 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular Disease
NCT04132791 ·Status: TERMINATED ·Phase: NA
-
A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin
NCT01214122 ·Status: WITHDRAWN ·Phase: PHASE1
-
Testing a Community Intervention to Increase Aspirin Use
NCT02607917 ·Status: COMPLETED ·Phase: NA
-
Perioperative Aspirin Response in Patients Undergoing Vascular Surgery
NCT03587324 ·Status: COMPLETED ·Phase: NA
-
Body Weight, Aspirin Dose and Pro-resolving Mediators
NCT04697719 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)
NCT00189618 ·Status: COMPLETED ·Phase: PHASE4
-
Coronary Artery Ectasia, Efficacy of Various Anti Thrombotic Regimens.
NCT05718531 ·Status: UNKNOWN ·Phase: PHASE3
-
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting
NCT01276691 ·Status: COMPLETED ·Phase: PHASE4
-
Ex Vivo Human Thrombosis Chamber Study
NCT00935506 ·Status: COMPLETED ·Phase: PHASE1
-
Aspirin Twice Daily in Diabetic Patients With Coronary Artery Disease
NCT01617031 ·Status: COMPLETED
-
Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event
NCT01395550 ·Status: COMPLETED
-
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
NCT00501345 ·Status: TERMINATED ·Phase: PHASE3
-
PPARGC1β and CNTN4 Genotype Aspirin Study
NCT02970604 ·Status: UNKNOWN ·Phase: PHASE4
-
ASA- and Clopidogrel-Responsiveness in Patients With Peripheral Arterial Occlusive Disease and Interventional Procedures
NCT00593762 ·Status: SUSPENDED
-
Monitoring Response to Antiplatelet Therapy
NCT00327041 ·Status: UNKNOWN
-
Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy
NCT02049762 ·Status: COMPLETED ·Phase: PHASE4
-
Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration
NCT00748371 ·Status: TERMINATED ·Phase: PHASE4
-
Aspirin Withdrawal in Non-ischaemic Cardiomyopathy Study
NCT01534026 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury
NCT01659307 ·Status: COMPLETED ·Phase: PHASE2